Medico Remedies Limited (MEDICO) — Strategic Asset Allocation Index
Medico Remedies Limited (MEDICO) has a Strategic Asset Allocation Index of 53.4% as of September 2022. Strategic assets (PP&E of Rs212.61 Million plus long-term investments of Rs-) total Rs212.61 Million, measured against net assets of Rs397.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MEDICO net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Medico Remedies Limited Strategic Asset Allocation Index (2020–2022)
This chart shows how Medico Remedies Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 53.4%, representing strategic assets of Rs212.61 Million against net assets of Rs397.86 Million INR. For live market cap and overall valuation, see MEDICO stock market capitalisation.
Annual Strategic Asset Allocation Index for Medico Remedies Limited (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Medico Remedies Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Medico Remedies Limited for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 43.1% | Rs160.90 Million | Rs160.90 Million | Rs- | Rs373.20 Million | ▼ -4.1 pp |
| 2021 | 47.2% | Rs153.10 Million | Rs153.10 Million | Rs- | Rs324.58 Million | ▼ -2.5 pp |
| 2020 | 49.6% | Rs148.28 Million | Rs148.28 Million | Rs- | Rs298.66 Million | — |